Clinical studies

The operation of ViviComb laser comb was subjected to clinical studies 7 times. The obtained results unanimously confirm high effectiveness (over 90% of people with positive results of the treatment) and a lack of side effects of using the laser.

During the study, positive effects of the therapy were observed in patients from more than 150 countries worldwide. Patients suffering from androgenic alopecia (the most common type of baldness) most often achieved positive results using the device. The producer repeatedly pointed out that, in addition to clinical studies, the key to the success of ViviComb laser comb were user experiences. Simultaneously, all this contributed to broadening the knowledge on treating hair loss.

In 2010 two key clinical studies dedicated to men and two that included women were carried out. A double-blind study was carried out in leading research centers, where the laser comb was checked for its suitability in the treatment of androgenic alopecia. Study duration was 6 months, while the target group consisted of patients aged 25 - 60. Hair length was measured at the beginning of the study and subsequently after 16 and 26 weeks. An increase in length and hair density was observed in the group of people who had been using ViviComb. After a period of 6 months, 100% of the subjects showed a substantial growth of new hair, while the average hair count in all patients increased by 20%.

Results of clinical studies showed the benefits achieved by people using ViviComb such as:

• a substantial decrease in the amount of hair falling out,
• increased rate of new hair growth,
• few patients immediately after starting the therapy experienced an initial increase in loss of hair in the telogen (resting) phase. However, after this period, the growth of hair in the anagen phase (active growth of hair) was observed,
• higher quality and improvement of hair condition.

The effect of using ViviComb laser after 6 months of treatment. Hair noticeably increased its density, overall hair condition has improved.

The area selected to investigate the change in hair density (delimited by the point indicating the center of the circle, 1 inch in diameter). The density was measured at the initial stage, and after 8, 16 and 26 weeks. A macro image was produced using FUJI S2 photography.

Details of clinical studies on ViviComb laser comb

People selected for the study were: both women and men aged 25-60 with diagnosed androgenic alopecia, who have experienced hair loss in the last 12 months prior to the therapy. The target group used the device 3 times a week for 15-20 minutes a day. All patients were randomized during the analysis of the laser comb therapy.

The studies were carried out in 8 research centers in the United States. All centers used the double-blind method in their studies. Hair density measurements were taken at the start of the study, immediately before randomization and again after 16 and 26 weeks.

The subjects were first diagnosed for the presence of androgenic alopecia; other dermatological diseases were ruled out. Then, the patients were randomized using ViviComb laser comb and fake devices that imitated the laser comb. The area of scalp was photographed for future evaluation. Next, the point being a basis for evaluating the change in hair density was identified and marked. In 8, 16 and 26 week of the study, each patient visited the clinic, where the results were read.